{"id":"https://openalex.org/W91334411","doi":null,"title":"The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions.","display_name":"The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions.","publication_year":2005,"publication_date":"2005-07-14","ids":{"openalex":"https://openalex.org/W91334411","mag":"91334411","pmid":"https://pubmed.ncbi.nlm.nih.gov/16124927"},"language":"en","primary_location":{"id":"pmid:16124927","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16124927","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087830645","display_name":"Pascal Bertholet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Pascal Bertholet","raw_affiliation_strings":["Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Li\u00e8ge, Belgium. p.bertholet@ulg.ac.be"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Li\u00e8ge, Belgium. p.bertholet@ulg.ac.be","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078474194","display_name":"Maud M. Gueders","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maud Gueders","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029080344","display_name":"Georges Dive","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Georges Dive","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103265305","display_name":"Adelin Albert","orcid":"https://orcid.org/0000-0003-3844-3774","observed_orcids":["https://orcid.org/0000-0003-3844-3774","https://orcid.org/0000-0003-1012-7331"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adelin Albert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012639218","display_name":"Val\u00e9ry Barillaro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valery Barillaro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105353921","display_name":"Bruno Perly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruno Perly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008558978","display_name":"Didier D Cataldo","orcid":"https://orcid.org/0000-0002-3079-7941","observed_orcids":["https://orcid.org/0000-0002-3079-7941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Didier Cataldo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084708096","display_name":"G\u00e9raldine Piel","orcid":"https://orcid.org/0000-0001-8632-4492","observed_orcids":["https://orcid.org/0000-0001-8632-4492","https://orcid.org/0000-0003-0624-8114"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G\u00e9raldine Piel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088938335","display_name":"Luc Delattre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luc Delattre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5090765919","display_name":"Brigitte \u00c9vrard","orcid":"https://orcid.org/0000-0002-2680-3931","observed_orcids":["https://orcid.org/0000-0002-2680-3931"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brigitte Evrard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9719,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.66410475,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"8","issue":"2","first_page":"163","last_page":"74"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclodextrins","display_name":"cyclodextrins","score":0.8970000147819519},{"id":"https://openalex.org/keywords/matrix-metalloproteinase-inhibitors","display_name":"matrix metalloproteinase inhibitors","score":0.8920000195503235},{"id":"https://openalex.org/keywords/water-solubility-enhancement","display_name":"aqueous solubility enhancement","score":0.9020000100135803},{"id":"https://openalex.org/keywords/inclusion-complexes","display_name":"inclusion complexes","score":0.9819999933242798},{"id":"https://openalex.org/keywords/dimethyl-beta-cyclodextrin","display_name":"dimethyl-\u03b2-cyclodextrin","score":0.8809999823570251},{"id":"https://openalex.org/keywords/gamma-cyclodextrin","display_name":"\u03b3-cyclodextrin","score":0.8700000047683716},{"id":"https://openalex.org/keywords/beta-cyclodextrin-derivatives","display_name":"\u03b2-cyclodextrin derivatives","score":0.8690000176429749},{"id":"https://openalex.org/keywords/phase-solubility","display_name":"phase solubility","score":0.800000011920929},{"id":"https://openalex.org/keywords/complex-stoichiometry","display_name":"complex stoichiometry","score":0.7239999771118164},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.5960000157356262},{"id":"https://openalex.org/keywords/bronchial-remodeling","display_name":"bronchial remodeling","score":0.8259999752044678},{"id":"https://openalex.org/keywords/hydrogen-bonding","display_name":"hydrogen bonding","score":0.9139999747276306}],"concepts":[{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.910430908203125},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7830920219421387},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.6062589883804321},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.4908076226711273},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.4600925147533417},{"id":"https://openalex.org/C168191866","wikidata":"https://www.wikidata.org/wiki/Q4551818","display_name":"Stability constants of complexes","level":3,"score":0.4562654495239258},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.4436769187450409},{"id":"https://openalex.org/C66974803","wikidata":"https://www.wikidata.org/wiki/Q10359898","display_name":"Nuclear magnetic resonance spectroscopy","level":2,"score":0.4239664077758789},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.28356921672821045},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.28063392639160156},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2250543236732483}],"mesh":[{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009330","descriptor_name":"Nebulizers and Vaporizers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011522","descriptor_name":"Protons","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014867","descriptor_name":"Water","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019999","descriptor_name":"Pharmaceutical Solutions","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D019999","descriptor_name":"Pharmaceutical Solutions","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D061965","descriptor_name":"Matrix Metalloproteinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:16124927","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16124927","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques","raw_type":"Comparative Study"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/2376","doi":null,"is_oa":false,"landing_page_url":"https://orbi.uliege.be/handle/2268/2376","pdf_url":null,"source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacy and Pharmaceutical Sciences, 8 (2), 164-175 (2005)","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"mag:91334411","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16124927","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W147653484","https://openalex.org/W1935587632","https://openalex.org/W1970830404","https://openalex.org/W1974208293","https://openalex.org/W1989546830","https://openalex.org/W1992962430","https://openalex.org/W1997434846","https://openalex.org/W1999087512","https://openalex.org/W2006486962","https://openalex.org/W2011873571","https://openalex.org/W2014635418","https://openalex.org/W2048704934","https://openalex.org/W2054616580","https://openalex.org/W2078384488","https://openalex.org/W2085355530","https://openalex.org/W2091072482","https://openalex.org/W2095054225","https://openalex.org/W2121464855","https://openalex.org/W2124132332","https://openalex.org/W2129039800","https://openalex.org/W2169469995","https://openalex.org/W2320975508"],"related_works":["https://openalex.org/W2133454001","https://openalex.org/W7000175343","https://openalex.org/W2071198570","https://openalex.org/W2014987430","https://openalex.org/W2520735615","https://openalex.org/W1986341493","https://openalex.org/W2414049641","https://openalex.org/W7218834569","https://openalex.org/W7128950181","https://openalex.org/W3081679584"],"abstract_inverted_index":{"PURPOSE:":[0],"Ro":[1],"28-2653":[2],"(RO)":[3],"is":[4,13,145,201],"a":[5,102,122,132,136],"synthetic":[6],"inhibitor":[7],"of":[8,40,84,95,189,207,235,239,245],"matrix":[9],"metalloproteinases":[10],"(MMPs),":[11],"which":[12,240],"potentially":[14],"effective":[15],"against":[16],"bronchial":[17],"remodeling.":[18],"Given":[19],"that":[20,116,143,163,196],"this":[21,41],"molecule":[22],"has":[23],"very":[24],"poor":[25],"aqueous":[26,223],"solubility,":[27],"different":[28],"cyclodextrins":[29],"(CDs)":[30],"have":[31],"been":[32],"tested":[33],"to":[34,44,47,57,80,147,174,185,216,220,231],"increase":[35],"its":[36,119,222],"solubility.":[37,224],"The":[38,62,111,225],"aim":[39],"study":[42,104,194],"was":[43,65,105],"prepare":[45],"and":[46,53,73,90,101,118,135,153,179,191,219],"characterize":[48],"inclusion":[49,86,210],"complexes":[50],"between":[51,88,177],"RO":[52,89,96,130,150,178,190,197,218],"CDs,":[54],"in":[55,199],"order":[56],"develop":[58,186],"nebulizable":[59,187,233],"solutions.":[60],"METHODS:":[61],"complex":[63,87,124,148],"formation":[64,176],"investigated":[66],"by":[67],"phase":[68,112],"solubility":[69,113],"studies.":[70],"(1)H-NMR":[71,168],"spectroscopy":[72],"molecular":[74,160],"modeling":[75,161],"studies":[76,114],"were":[77,97,183],"carried":[78],"out":[79],"elucidate":[81],"the":[82,85,164,192,205,208,237,243,246],"structure":[83],"dimethyl-beta-CD":[91],"(DIMEB).":[92],"Nebulizable":[93],"solutions":[94,188,234],"developed":[98],"with":[99,125,131,156,167],"CDs":[100,182,213],"stability":[103,138,193,238],"performed":[106],"over":[107],"9":[108],"months.":[109],"RESULTS:":[110],"showed":[115,142],"beta-CD":[117,226],"derivatives":[120,227],"form":[121],"1:2":[123,209,247],"RO,":[126,236],"whereas":[127],"gamma-CD":[128],"includes":[129],"1:1":[133],"stoichiometry":[134],"weak":[137],"constant.":[139],"T-ROESY":[140],"spectra":[141],"DIMEB":[144],"able":[146,215],"two":[149],"substituents":[151],"(nitrophenyl":[152],"biphenyl":[154],"groups)":[155],"preferential":[157],"orientations,":[158],"while":[159],"demonstrated":[162,195],"configurations":[165],"observed":[166],"are":[169,214],"energetically":[170],"favorable,":[171],"especially":[172],"owing":[173],"H-bond":[175],"DIMEB.":[180],"Two":[181],"selected":[184],"degradation":[198],"solution":[200],"strongly":[202],"dependent":[203],"on":[204,242],"concentration":[206,244],"complex.":[211,248],"CONCLUSIONS:":[212],"include":[217],"improve":[221],"can":[228],"be":[229],"used":[230],"formulate":[232],"depends":[241]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}